Health
Rheumatoid Arthritis Drug Baricitinib Linked to Reduced Mortality in COVID-19 Patients – Cath Lab Digest
November 13, 2020 — The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according…
November 13, 2020 The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden. The findings, published in the journal Science Advances, support the continuation of ongoing randomized clinical trials.
We are pleased to report a 71 percent reduction in mortality for the group receiving baricitinib in addition…
-
Noosa News23 hours agoMeasles alert issued across popular south-east attractions
-
General23 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
General17 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News7 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred